Notably, these lymphomas had poorer clinical outcomes, low genomic instability, an upregulation of immune pathways involving NF-κB, IFNγ, and IL6-JAK-STAT3, and downregulation of EBV miRNA when compared to classical NKTCL. This evidence concerns the gene IL6 and extranodal nasal NK/T cell lymphoma.